Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Interest & Investment Income of $228000.0 for Q4 2025, down 42.86% year-on-year from $399000.0 in Q4 2024, and up 50.0% on a QoQ basis from $152000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Interest & Investment Income data on file, last reported at $228000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 42.86% year-over-year to $228000.0; the trailing twelve-month figure through Dec 2025 stood at $787000.0 (down 53.21% YoY), and the FY2025 full-year result was $787000.0, down 53.21% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $228000.0, up from $152000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $570000.0 in Q2 2024 and bottomed at $9000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $115000.0 (2023), against an average of $157950.0.
- The widest annual swing landed in 2023, when Interest & Investment Income jumped 1177.78%; it then slumped 70.54% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $13000.0 in 2021, then jumped by 1076.92% to $153000.0 in 2022, then slipped by 24.84% to $115000.0 in 2023, then soared by 246.96% to $399000.0 in 2024, then tumbled by 42.86% to $228000.0 in 2025.
- The last three Interest & Investment Income figures came in at $228000.0 (Q4 2025), $152000.0 (Q3 2025), and $171000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 228,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 171,000.00 |
| Mar 31, 2025 | 236,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Sep 30, 2024 | 516,000.00 |
| Jun 30, 2024 | 570,000.00 |
| Mar 31, 2024 | 197,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 115,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 153,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | 13,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 16,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 17,000.00 |
| Mar 31, 2020 | 35,000.00 |
| Dec 31, 2019 | 69,000.00 |
| Sep 30, 2019 | 70,000.00 |
| Jun 30, 2019 | 110,000.00 |
| Mar 31, 2019 | 66,000.00 |
| Dec 31, 2018 | 115,000.00 |
| Sep 30, 2018 | 101,000.00 |
| Jun 30, 2018 | 73,000.00 |
| Mar 31, 2018 | 59,000.00 |
| Dec 31, 2017 | 23,000.00 |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 5,000.00 |
| Mar 31, 2017 | 3,000.00 |
| Dec 31, 2016 | 2,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 3,000.00 |
| Sep 30, 2015 | 1,000.00 |
| Jun 30, 2015 | 1,000.00 |
| Mar 31, 2015 | 1,000.00 |
| Dec 31, 2014 | 1,000.00 |
| Jun 30, 2014 | 3,000.00 |
| Mar 31, 2014 | -2,000.00 |
| Dec 31, 2013 | -1,000.00 |
| Jun 30, 2013 | -3,000.00 |
| Mar 31, 2013 | 2,000.00 |
| Dec 31, 2012 | 12,000.00 |
| Sep 30, 2012 | 5,000.00 |
| Jun 30, 2012 | 3,000.00 |
| Mar 31, 2012 | 8,000.00 |
| Dec 31, 2011 | 14,000.00 |
| Sep 30, 2011 | 21,000.00 |
| Jun 30, 2011 | -1,000.00 |
| Mar 31, 2011 | 10,000.00 |
| Dec 31, 2010 | 11,000.00 |
| Sep 30, 2010 | 13,000.00 |
| Jun 30, 2010 | 8,000.00 |